Terms: = Colorectal cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
7 results:
1. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
Su X; Zhang H; Wang Y
J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic colorectal cancer.
Nemeth Z; Wijker W; Lengyel Z; Hitre E; Borbely K
Pathol Oncol Res; 2020 Oct; 26(4):2683-2691. PubMed ID: 32661836
[TBL] [Abstract] [Full Text] [Related]
3. Radiomics analysis of pre-treatment [
van Helden EJ; Vacher YJL; van Wieringen WN; van Velden FHP; Verheul HMW; Hoekstra OS; Boellaard R; Menke-van der Houven van Oordt CW
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2307-2317. PubMed ID: 30094460
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma.
Saka B; Ekinci O; Dursun A; Akyurek N
Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753
[TBL] [Abstract] [Full Text] [Related]
5. PET-based treatment response evaluation in rectal cancer: prediction and validation.
Janssen MH; Öllers MC; van Stiphout RG; Riedl RG; van den Bogaard J; Buijsen J; Lambin P; Lammering G
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):871-6. PubMed ID: 21377810
[TBL] [Abstract] [Full Text] [Related]
6. Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials.
Drevs J; Zirrgiebel U; Schmidt-Gersbach CI; Mross K; Medinger M; Lee L; Pinheiro J; Wood J; Thomas AL; Unger C; Henry A; Steward WP; Laurent D; Lebwohl D; Dugan M; Marmé D
Ann Oncol; 2005 Apr; 16(4):558-65. PubMed ID: 15705616
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters.
Rau B; Wust P; Tilly W; Gellermann J; Harder C; Riess H; Budach V; Felix R; Schlag PM
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):381-91. PubMed ID: 10974451
[TBL] [Abstract] [Full Text] [Related]
